Hims & Hers Health (HIMS)
(Real Time Quote from BATS)
$21.52 USD
-0.23 (-1.06%)
Updated Jun 6, 2024 10:22 AM ET
1-Strong Buy of 5 1
D Value A Growth D Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HIMS 21.52 -0.23(-1.06%)
Will HIMS be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for HIMS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HIMS
IDEXX (IDXX) Expands Test Menu for the Catalyst Platform
5 Phenomenal Relative Price Strength Stocks to Snap Up Now
HIMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Acrivon Therapeutics, Inc. (ACRV) Outperforming Other Medical Stocks This Year?
QIAGEN's (QGEN) New Launch Expands US Syndromic Testing Menu
Here's Why You Should Hold on to Tandem Diabetes (TNDM) Now
Other News for HIMS
10 Health Care Stocks With Whale Alerts In Today's Session
Hims and Hers Health call volume above normal and directionally bullish
Kimberly-Clark To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Hims & Hers price target raised by $4.75 at BofA, here's why
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Inspire Medical Systems (INSP) and Autolus Therapeutics (AUTL)